Trends in participant race and sex reporting in lung cancer phase III clinical trials
Abstract Background Clinical trials are an essential part of advancing care for cancer patients. Historically, however, racial minorities and females have been underrepresented in these trials. Efforts like the National Institute of Health Revitalization Act attempted to mitigate these disparities,...
Main Authors: | Faaiq N. Aslam, Rami Manochakian, Yanyan Lou, Gerardo Colon‐Otero, Taimur Sher |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2023-09-01
|
Series: | Cancer Reports |
Subjects: | |
Online Access: | https://doi.org/10.1002/cnr2.1856 |
Similar Items
-
Genomic landscape of lung adenocarcinomas in different races
by: Huashan Shi, et al.
Published: (2022-09-01) -
Sex and Race‐Ethnic Disparities in Door‐to‐CT Time in Acute Ischemic Stroke: The Florida Stroke Registry
by: Sai P. Polineni, et al.
Published: (2021-04-01) -
Landmark Cancer Clinical Trials and Real-World Patient Populations: Examining Race and Age Reporting
by: Thejus Jayakrishnan, et al.
Published: (2021-11-01) -
Pancreatic Cancer Incidence Trends by Race, Ethnicity, Age and Sex in the United States: A Population-Based Study, 2000–2018
by: Jamil S. Samaan, et al.
Published: (2023-01-01) -
Sex Disparities in Productivity among Oculoplastic Surgeons
by: Mckenzee Chiam, et al.
Published: (2021-07-01)